Why Novavax Stock Surged Today

Why Novavax Stock Surged Today

Shares of Novavax (NASDAQ: NVAX) climbed 10% on Friday after the biotechnology company reached a coronavirus vaccine supply deal with the United Kingdom. Novavax will supply the U.K. with 60 million doses of its COVID-19 vaccine candidate, NVX-CoV2373. The biotech is also planning a phase 3 study to test the effectiveness of the vaccine among participants from the U.K.